login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BIONANO GENOMICS INC (BNGO) Stock News
USA
- NASDAQ:BNGO -
US09075F4046
-
Common Stock
1.62
USD
+0.13 (+8.72%)
Last: 11/21/2025, 7:15:44 PM
1.61
USD
-0.01 (-0.62%)
After Hours:
11/21/2025, 7:15:44 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BNGO Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: The Motley Fool
Bionano (BNGO) Q3 2025 Earnings Call Transcript
8 days ago - By: Bionano Genomics
Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
16 days ago - By: Zacks Investment Research
- Mentions:
KROS
Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates
17 days ago - By: Zacks Investment Research
- Mentions:
EXEL
Exelixis (EXEL) Beats Q3 Earnings and Revenue Estimates
22 days ago - By: Bionano Genomics
Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025
2 months ago - By: Bionano Genomics
Bionano to Participate in the H.C. Wainwright @ Home Event
3 months ago - By: The Motley Fool
Bionano Genomics Posts Q2 Margin Gain
3 months ago - By: Benzinga
A Preview Of Bionano Genomics's Earnings
6 months ago - By: Stocktwits
Bionano Genomics Retail Mood Turns ‘Extremely Bearish’ Amid Revenue Guidance Shortfall
9 days ago - By: Benzinga
- Mentions:
ECC
VINP
INV
VTGN
...
Earnings Scheduled For November 13, 2025
9 days ago - By: Zacks Investment Research
- Mentions:
IBIO
iBio, Inc. (IBIO) Reports Q1 Loss
2 months ago - By: Bionano Genomics
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
2 months ago - By: Bionano Genomics
Bionano Genomics, Inc. Announces Pricing of $10 Million Public Offering
2 months ago - By: Bionano Genomics
Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology
2 months ago - By: Bionano Genomics
CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders
2 months ago - By: Zacks Investment Research
Despite Fast-paced Momentum, Bionano Genomics (BNGO) Is Still a Bargain Stock
3 months ago - By: Zacks Investment Research
Bionano Genomics (BNGO) Is Attractively Priced Despite Fast-paced Momentum
3 months ago - By: Bionano Genomics
Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress
4 months ago - By: Bionano Genomics
Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL
4 months ago - By: Bionano Genomics
Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference
5 months ago - By: Bionano Genomics
Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy
6 months ago - By: Bionano Genomics
Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress
6 months ago - By: Zacks Investment Research
- Mentions:
ABSI
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
Please enable JavaScript to continue using this application.